We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform

News   Mar 26, 2012

 
Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform
 
 
 

RELATED ARTICLES

The "Secret Weapon" of Virus-Neutralizing Antibodies

News

A new study in mice has explored why certain antibodies are highly effective in protecting the body against debilitating viruses like chikungunya.

READ MORE

Japan Approves Stem Cell Therapy for Spinal Cord Injuries

News

A stem cell therapy has been given the green light for the treatment of spinal cord injuries, and a follow-up trial is set to begin later this year. However, independent researchers warn that the approval is premature.

READ MORE

Multi-organ "Human-on-a-Chip" Enables Long-term Toxicology Testing

News

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE